[Federal Register Volume 78, Number 97 (Monday, May 20, 2013)]
[Notices]
[Pages 29388-29389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-11947]


-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (13-059)]


Notice of Intent To Grant Exclusive License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of Intent to Grant Exclusive License.

-----------------------------------------------------------------------

SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(e) and 
37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant 
an exclusive license in the United States to practice the inventions 
described and claimed in USPN 8,338,114, Engineering Human Broncho-
Epithelial Tissue-Like Assemblies, NASA Case No. MSC-24164-1; US Patent 
Application Serial Number 12/899,815, Modifying the Genetic Regulation 
of Bone and Cartilage Cells and Associated Tissue by EMF Stimulation 
Fields and Uses Thereof, NASA Case No. MSC-24541-1; and US Patent 
Application Serial Number 13/859,180, Alternating Ionic Magnetic 
Resonance (AIMR) Multiple-Chambered Culture Apparatus, NASA Case No. 
MSC-25545-1; and US Patent Application Serial Number 13/859,206,

[[Page 29389]]

Methods for Culturing Cells in an Alternating Ionic Magnetic Resonance 
(AIMR) Multiple-Chambered Culture Apparatus, NASA Case No. MSC-25633-1, 
to GRoK Technologies, LLC, having its principal place of business in 
Houston, Texas. The patent rights in these inventions have been 
assigned to the United States of America as represented by the 
Administrator of the National Aeronautics and Space Administration. The 
prospective exclusive license will comply with the terms and conditions 
of 35 U.S.C. 209 and 37 CFR 404.7.

DATES: The prospective exclusive license may be granted unless within 
fifteen (15) days from the date of this published notice, NASA receives 
written objections including evidence and argument that establish that 
the grant of the license would not be consistent with the requirements 
of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and 
received by NASA within fifteen (15) days of the date of this published 
notice will also be treated as objections to the grant of the 
contemplated exclusive license.
    Objections submitted in response to this notice will not be made 
available to the public for inspection and, to the extent permitted by 
law, will not be released under the Freedom of Information Act, 5 
U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, NASA Johnson 
Space Center, 2101 NASA Parkway, Houston, Texas 77058, Mail Code AL; 
Phone (281) 483-3021; Fax (281) 483-6936.

FOR FURTHER INFORMATION CONTACT: Ted Ro, Intellectual Property 
Attorney, Office of Chief Counsel, NASA Johnson Space Center, 2101 NASA 
Parkway, Houston, Texas 77058, Mail Code AL; Phone (281) 244-7148; Fax 
(281) 483-6936. Information about other NASA inventions available for 
licensing can be found online at http://technology.nasa.gov/.

Sumara M. Thompson-King,
Deputy General Counsel.
[FR Doc. 2013-11947 Filed 5-17-13; 8:45 am]
BILLING CODE 7510-13-P